Completed
Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease
NCT06482437
- Conditions
- Charcot-Marie-Tooth Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
- Locations
-
- University of Kansas Medical Center, Department of Neurology Kansas City, Kansas, United States
- Mass General Neurology Boston, Massachusetts, United States
- NextGen Precision Health Columbia, Missouri, United States
- Columbia University Medical Center New York, United States